Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-19

Clinical Trial Update: Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial sponsored by Tr1X, Inc. is currently recruiting to evaluate a treatment for Primary Progressive Multiple Sclerosis and Secondary Prog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tr1X, Inc. | Conditions: Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis (SPMS) | Phase 1, Phase 2 | Status: RECRUITING